[PHARMA] YoY Cumulative Quarter Result on 30-Jun-2009 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
21-Aug-2009
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2009
Quarter
30-Jun-2009 [#2]
Profit Trend
QoQ- 121.86%
YoY- 1.79%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
Revenue 903,482 781,763 667,895 646,928 663,115 556,466 501,887 10.28%
PBT 70,573 41,172 32,758 44,521 48,462 22,411 17,177 26.52%
Tax -25,435 -11,528 -8,931 -11,305 -16,023 -8,701 -5,364 29.58%
NP 45,138 29,644 23,827 33,216 32,439 13,710 11,813 25.00%
-
NP to SH 44,398 29,404 24,054 32,219 31,652 12,709 10,935 26.27%
-
Tax Rate 36.04% 28.00% 27.26% 25.39% 33.06% 38.82% 31.23% -
Total Cost 858,344 752,119 644,068 613,712 630,676 542,756 490,074 9.78%
-
Net Worth 481,282 451,381 417,306 400,063 362,623 314,515 316,549 7.22%
Dividend
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
Div 17,650 - 50,290 28,881 19,254 16,046 12,298 6.20%
Div Payout % 39.76% - 209.07% 89.64% 60.83% 126.26% 112.47% -
Equity
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
Net Worth 481,282 451,381 417,306 400,063 362,623 314,515 316,549 7.22%
NOSH 117,672 106,962 107,001 106,968 106,968 106,978 106,942 1.60%
Ratio Analysis
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
NP Margin 5.00% 3.79% 3.57% 5.13% 4.89% 2.46% 2.35% -
ROE 9.22% 6.51% 5.76% 8.05% 8.73% 4.04% 3.45% -
Per Share
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
RPS 767.79 730.88 624.19 604.78 619.92 520.17 469.31 8.54%
EPS 37.73 27.49 22.48 30.12 29.59 11.88 10.22 24.29%
DPS 15.00 0.00 47.00 27.00 18.00 15.00 11.50 4.52%
NAPS 4.09 4.22 3.90 3.74 3.39 2.94 2.96 5.53%
Adjusted Per Share Value based on latest NOSH - 106,995
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
RPS 62.69 54.24 46.34 44.89 46.01 38.61 34.82 10.28%
EPS 3.08 2.04 1.67 2.24 2.20 0.88 0.76 26.24%
DPS 1.22 0.00 3.49 2.00 1.34 1.11 0.85 6.20%
NAPS 0.3339 0.3132 0.2895 0.2776 0.2516 0.2182 0.2196 7.22%
Price Multiplier on Financial Quarter End Date
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
Date 29/06/12 30/06/11 30/06/10 30/06/09 30/06/08 29/06/07 30/06/06 -
Price 10.18 5.90 4.98 3.80 3.27 3.53 4.51 -
P/RPS 1.33 0.81 0.80 0.63 0.53 0.68 0.96 5.57%
P/EPS 26.98 21.46 22.15 12.62 11.05 29.71 44.11 -7.85%
EY 3.71 4.66 4.51 7.93 9.05 3.37 2.27 8.52%
DY 1.47 0.00 9.44 7.11 5.50 4.25 2.55 -8.76%
P/NAPS 2.49 1.40 1.28 1.02 0.96 1.20 1.52 8.56%
Price Multiplier on Announcement Date
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
Date 08/08/12 10/08/11 11/08/10 21/08/09 14/08/08 17/08/07 16/08/06 -
Price 8.83 5.90 4.95 4.00 3.44 3.44 4.00 -
P/RPS 1.15 0.81 0.79 0.66 0.55 0.66 0.85 5.16%
P/EPS 23.40 21.46 22.02 13.28 11.63 28.96 39.12 -8.20%
EY 4.27 4.66 4.54 7.53 8.60 3.45 2.56 8.89%
DY 1.70 0.00 9.49 6.75 5.23 4.36 2.88 -8.40%
P/NAPS 2.16 1.40 1.27 1.07 1.01 1.17 1.35 8.14%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment